STOCK TITAN
  1. Home
  2. Sec-filings
  3. GOVXW
  4. [EFFECT] GeoVax Labs, Inc. Warrants SEC Filing

[EFFECT] GeoVax Labs, Inc. Warrants SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
Rhea-AI Filing Summary
Riscrivi il testo seguente:
Reescribe el siguiente texto:
다음 텍스트를 다시 작성하세요:
Réécrivez le texte suivant :
Schreibe den folgenden Text um:
Positive
  • None.
Negative
  • None.
Riscrivi il testo seguente:
Reescribe el siguiente texto:
다음 텍스트를 다시 작성하세요:
Réécrivez le texte suivant :
Schreibe den folgenden Text um:
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 30, 2025 5:00 P.M.
Form: S-1
CIK: 0000832489
Company Name: GeoVax Labs, Inc.
File Number: 333-288085

Source: View Original Filing on SEC EDGAR

Stock GOVXW logo
Geovax Labs Inc

NASDAQ:GOVXW

GOVXW Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

GOVXW Latest News

Dec 9, 2024
GeoVax Receives Notice of Allowance For Cancer Vaccine Patent
Nov 26, 2024
GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference
Nov 19, 2024
GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia
Nov 12, 2024
GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update
Nov 5, 2024
GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

GOVXW Latest SEC Filings

Jul 2, 2025
[8-K] GeoVax Labs, Inc. Warrants Reports Material Event
Jul 2, 2025
[424B4] GeoVax Labs, Inc. Warrants Prospectus Filed Pursuant to Rule 424(b)(4)
Jun 26, 2025
[S-1/A] GeoVax Labs, Inc. Warrants Amends IPO Registration Statement

GOVXW Stock Data

2.35M
Biotechnology
Pharmaceutical Preparations
Link
United States
SMYRNA